PTC THERAPEUTICS INC - NOTE 1.500% 9/1
Historical Holders from Q2 2022 to Q4 2025
-
Type / Class
-
Debt / NOTE 1.500% 9/1
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F principal, excl. options
-
278,232,000
-
Holdings value
-
$296,027,478
-
% of all portfolios
-
0%
-
Number of holders
-
15
-
Number of buys
-
3
-
Number of sells
-
5
-
Average buys %
-
+0%
-
Average sells %
-
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
16 filings reported holding 69366JAD3 - PTC THERAPEUTICS INC - NOTE 1.500% 9/1 as of 30 Sep 2025.
PTC THERAPEUTICS INC - NOTE 1.500% 9/1 has 15 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $278,232,000 principal (par value or face value) of the bond.
Institutional Holders of PTC THERAPEUTICS INC - NOTE 1.500% 9/1 across Reporting Periods
| Period |
Principal |
Value |
Change |
Price |
Investors |
|
2025 Q4
|
227,000
|
$336,391
|
-$87,432
|
$1.48
|
1
|
|
2025 Q3
|
278,232,000
|
$296,027,478
|
+$725,502
|
$1.28
|
15
|
|
2025 Q2
|
275,383,000
|
$318,055,093
|
-$3,252,102
|
$1.15
|
15
|
|
2025 Q1
|
276,612,000
|
$326,799,984
|
+$764,592
|
$1.17
|
14
|
|
2024 Q4
|
264,421,591
|
$309,275,303
|
-$20,168,580
|
$1.12
|
13
|
|
2024 Q3
|
259,449,591
|
$309,774,451
|
+$582,114
|
$1.04
|
12
|
|
2024 Q2
|
259,449,591
|
$284,800,544
|
+$182,994
|
$0.9540
|
12
|
|
2024 Q1
|
274,717,308
|
$277,129,832
|
-$20,916,765,749
|
$0.9325
|
14
|
|
2023 Q4
|
287,509,503
|
$273,105,852
|
+$15,160,001
|
$0.9188
|
14
|
|
2023 Q3
|
278,652,272
|
$229,332,855
|
-$3,058,195
|
$0.7970
|
20
|
|
2023 Q2
|
287,637,000
|
$296,005,222
|
-$2,491,781
|
$1.03
|
19
|
|
2023 Q1
|
279,704,527
|
$327,735,385
|
+$7,856,990
|
$1.14
|
17
|
|
2022 Q4
|
287,400,000
|
$284,218,480
|
-$1,258,207
|
$0.9854
|
10
|
|
2022 Q3
|
287,600,000
|
$336,226,000
|
+$32,736,045
|
$1.17
|
11
|
|
2022 Q2
|
262,509,000
|
$275,443,000
|
+$275,443,000
|
$1.05
|
10
|